News tagged with 'Relenza'

The death of a New York City assistant principal from swine flu bring the U.S. death toll to 6, while the World Health Organization meets in Geneva to discuss how pharmaceutical companies can patent the virus to developing a vaccine.

With swine flu still spreading, global health officials are warning countries to limit use of antiviral drugs, used to treat influenza, to only high-risk patients such as pregnant women and chronically ill patients to ensure adequate supplies.

Relenza (zanamivir), an anti-influenza product delivered through an inhaler, has been reported to be difficult to use by the elderly population. The maker of Relenza, Glaxosmithkline PLC, recently reported that many of the elderly patients who attempt to use the inhaler are unable to do so. Dr. Paul Diggory, on s